$3.36
-0.17-4.82%
Last update: Oct 23, 7:54 PM
Zura Bio Ltd (ZURA) Stock Price, Quote, News & History
ZURANASDAQ
William Blair starts Zura Bio (NASDAQ: ZURA) at Outperform, citing tibulizumab's multibillion-dollar potential in autoimmune disease.
You can purchase shares of Zura Bio (NASDAQ:ZURA) through any online brokerage.
Other companies in Zura Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Zura Bio has a consensus price target of $14.45.
The stock price for Zura Bio (NASDAQ: ZURA) is $3.45 last updated October 23, 2026 at 7:54 PM EDT.
There are no upcoming dividends for Zura Bio.
Zura Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Zura Bio.
Zura Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic,...
